...
首页> 外文期刊>International journal of clinical oncology >The significance of micro-lymphatic invasion and pathological Gleason score in prostate cancer patients with pathologically organ-confined disease and negative surgical margins after robot-assisted radical prostatectomy
【24h】

The significance of micro-lymphatic invasion and pathological Gleason score in prostate cancer patients with pathologically organ-confined disease and negative surgical margins after robot-assisted radical prostatectomy

机译:在机器人辅助自由基前列腺切除术后前列腺癌患者的微淋巴侵袭和病理肠道患者的重要性。

获取原文
获取原文并翻译 | 示例
           

摘要

Background The development process of recurrence in prostate cancer patients with pathologically organ-confined (pT2) disease and negative surgical margins is unclear. The aim of the present study was to determine factors associated with the development of biochemical recurrence following robot-assisted radical prostatectomy among those prostate cancer patients. Methods We retrospectively reviewed the data of patients who underwent robot-assisted radical prostatectomy without neoadjuvant endocrine therapy. We evaluated prognostic factors in 1096 prostate cancer patients with pT2 disease and negative surgical margins. Univariate and multivariate Cox proportional hazards regression analyses were used to identify independent predictors for biochemical recurrence. Results Of the 1096 patients, 55 experienced biochemical recurrence during the follow-up period. The 5-year biochemical recurrence-free survival rate for patients with pT2 and negative surgical margins was 91.8%. On univariate analysis, clinical stage, biopsy Gleason score, percent of positive core, pathological Gleason score, and the presence of micro-lymphatic invasion were significantly associated with biochemical recurrence. On a multivariate analysis, the presence of micro-lymphatic invasion and a pathological Gleason score >= 4 + 3 were significant prognostic factors for biochemical recurrence. Based on these factors, we developed a risk stratification model. The biochemical recurrence-free survival rate differed significantly among the risk groups. Conclusions The prognosis of prostate cancer patients with pT2 disease and negative surgical margins is favorable. However, patients with the presence of micro-lymphatic invasion and a pathological Gleason score >= 4 + 3 tend to experience biochemical recurrence more often after surgery. Therefore, careful follow-up might be necessary for those patients.
机译:背景技术癌症癌症患者在病理学器官局限性(PT2)疾病和阴性外科患者中复发的发育过程尚不清楚。本研究的目的是确定与那些前列腺癌患者的机器人辅助的自由基前列腺切除术后生化复发相关的因素。方法我们回顾性地审查了未经Neoadjuvant内分泌治疗的机器人辅助自由基前列腺切除术的患者的数据。我们评估了1096例前列腺癌患者的预后因素,PT2疾病和阴性手术边缘。单变量和多元COX比例危害回归分析用于识别生化复发的独立预测因子。 1096例患者的结果,55例后续期间经历了生化复发。 PT2和阴性手术边距患者的5年生化复发存活率为91.8%。在单变量分析,临床阶段,活检格里森评分,阳性核心,病理肠胃逝分的百分比和微淋巴侵入的存在与生化复发显着相关。在多变量分析中,微淋巴侵袭的存在和病理肠胃胺评分> = 4 + 3是生化复发的显着预后因素。根据这些因素,我们开发了一种风险分层模型。在风险群体中,生化复发的存活率显着不同。结论PT2疾病和阴性外科患者的前列腺癌患者的预后是有利的。然而,患有微淋巴侵入和病理肠胃胺评分的患者= 4 + 3往往在手术后经历生化复发。因此,这些患者可能需要仔细随访。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号